Auden McKenzie, Waymade hydrocortisone probe extended by UK CMA
MLex Summary: The UK's Competition and Markets Authority has extended a drug-pricing probe, after it provisionally found that pharmaceutical companies Auden McKenzie and Waymade broke competition law by agreeing not to...To view the full article, register now.
Already a subscriber? Click here to view full article